NeuroNext biomarker study explores natural history of infantile-onset SMA

January 9, 2018, The Ohio State University

Research led by The Ohio State University Wexner Medical Center to define the natural history of infantile-onset spinal muscular atrophy (SMA) has been "critical" to accelerate the development of effective therapies and hasten their approval by the FDA," said principal investigator Dr. Stephen J. Kolb, director of the OSU ALS/Motor Neuron Disease Translational Research Program at Ohio State's Neurological Institute.

Findings of the study are published online in the journal Annals of Neurology.

"Clinical in this population require an understanding of disease progression and identification of meaningful biomarkers to hasten therapeutic development and predict outcomes," Kolb said. "This study has generated definitive controlled data on the natural history of infantile-onset SMA. With the advent of effective disease-modifying therapies, it's likely not ethical or feasible to perform future clinical trials that have a placebo arm in which sick children don't receive available treatment. Thus, our data sets are critical for future investigation of improved therapies."

SMA is an inherited condition that causes nerve cells in the lower part of the brain and spinal cord to break down and die. The infantile-onset form is the leading genetic cause of infant death, typically before age two.

The study assessed infant motor function scales and possible electrophysiological, protein and molecular biomarkers at baseline and subsequent visits for 27 healthy and 26 infants with the most severe form of SMA. A total of 23 healthy infants and seven SMA infants completed the study, and the median age of survival for infants with two copies of the SMN2 gene was eight months.

According to an accompanying editorial in the Annals of Neurology, this study is "already serving as the gold standard for the natural history of untreated infantile SMA."

"The control infant data obtained here is also novel, contributes to our understanding of postnatal neuromuscular development and provides a first benchmark to indicate full recovery in SMA trials and optimal clinical management," Kolb said. "Considerations for effective clinical trial design in infantile-onset SMA can be gleaned from this study and recent ."

The study was a prospective, multi-center, longitudinal study in SMA and healthy infants designed to mimic a clinical trial. The protocol, patient demographics and baseline characteristics were published previously.

Explore further: Researchers seek biomarker to assess spinal muscular atrophy treatment

More information: Stephen J. Kolb et al. Natural history of infantile-onset spinal muscular atrophy, Annals of Neurology (2017). DOI: 10.1002/ana.25101

Related Stories

Researchers seek biomarker to assess spinal muscular atrophy treatment

June 19, 2017
Spinal muscular atrophy (SMA) is the leading genetic cause of death in infants, affecting 1 in 11,000 live births. As promising new therapies such as those directly targeting survivor motor neuron (SMN) are entering clinical ...

Study finds new treatment for spinal muscular atrophy safe for infants

December 6, 2016
Infants as young as five weeks old with the most severe form of spinal muscular atrophy (SMA) - a leading genetic cause of infant mortality - can be treated safely with nusinersen. This investigational treatment slowed progression ...

New study focuses on treatment for epilepsy caused by tuberous sclerosis

May 8, 2017
A clinical trial of a drug that researchers hope can prevent or delay the onset of epilepsy in children with tuberous sclerosis has begun at McGovern Medical School at The University of Texas Health Science Center at Houston ...

Phase 1 study shows encouraging data for gene replacement therapy for SMA type I

November 1, 2017
A one-time intravenous infusion of the high dose of gene therapy extended the survival of patients with spinal muscular atrophy type 1 (SMA1) in a Phase 1 clinical trial, according to a study published today in the New England ...

Drug study first effort to prevent onset of epilepsy in tuberous sclerosis complex

October 18, 2016
Researchers at the University of Alabama at Birmingham have launched the first drug study aimed at preventing or delaying the onset of epilepsy in children with a genetic condition known as tuberous sclerosis complex. UAB ...

L. reuteri DSM17938 effective for colic in breastfed infants

December 27, 2017
(HealthDay)—Lactobacillus reuteri DSM17938 is effective for breastfed infants with colic, according to a meta-analysis published online Dec. 26 in Pediatrics.

Recommended for you

Early childhood interventions show mixed results on child development

April 24, 2018
Early childhood interventions may have some efficacy in boosting measures of child health and development in low income countries, but more work is needed to sort out how to implement these interventions, according to a new ...

New study shows prenatal cannabis use associated with low birth weights

April 23, 2018
With marijuana use during pregnancy on the rise, a new study led by the Colorado School of Public Health shows that prenatal cannabis use was associated with a 50 percent increased likelihood of low birth weight, setting ...

New research suggests possible link between sudden infant death syndrome and air pollution

April 20, 2018
A study led by the University of Birmingham suggests a possible association between exposure to certain pollutants and an increased risk of so-called 'cot death'.

Common antidepressants in pregnancy may alter fetal brain development

April 10, 2018
(HealthDay)—Pregnant women who take certain antidepressants may unknowingly compromise the brain development of their child, researchers suggest.

Kids in tough neighborhoods head to ER more often

April 6, 2018
(HealthDay)—Growing up in a disadvantaged neighborhood may mean more visits to the emergency room, a new study suggests.

Infant death study reveals dangerous sleep practices among babysitters, relatives, others

April 2, 2018
Babies who died during their sleep while being watched by someone other than parents often had been placed in unsafe sleep positions, such as on their stomachs, or in unsafe locations, such as a couch, a new study has found.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.